The ESCRT protein CHMP5 promotes T cell leukemia by controlling BRD4-p300-dependent transcription
Katharine Umphred-WilsoniD, Shashikala RatnayakeiD, Qianzi TangiD, Rui WangiD, Sneha Ghosh ChaudharyiD, Ballachanda N. DevaiahiD, Josephine TrichkaiD, Jan WiśniewskiiD, Lan ZhouiD, Qingrong CheniD, Daoud M. MeerzamaniD, Dinah S. SingeriD, Stanley AdoroiD
Abstract
Oncogene activity rewires cellular transcription, creating new transcription networks to which cancer cells become addicted, by mechanisms that are still poorly understood. Using human and mouse models of T cell acute lymphoblastic leukemia (T-ALL), we identify an essential nuclear role for CHMP5, a cytoplasmic endosomal sorting complex required for transport (ESCRT) protein, in establishing and maintaining the T-ALL transcriptional program. Nuclear CHMP5 promoted the T-ALL gene program by augmenting recruitment of the co-activator BRD4 by the histone acetyl transferase p300 selectively at enhancers and super-enhancers, an interaction that potentiated H3K27 acetylation at these regulatory enhancers. Consequently, loss of CHMP5 diminished BRD4 occupancy at enhancers and super-enhancers and impaired RNA polymerase II pause release, which resulted in downregulation of key T-ALL genes, notably MYC. Reinforcing its importance in T-ALL pathogenesis, CHMP5 deficiency mitigated chemoresistance in human T-ALL cells and abrogated T-ALL induction by oncogenic NOTCH1 in vivo. Thus, the ESCRT protein CHMP5 is an essential positive regulator of the transcriptional machinery promoting T-ALL disease. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/577409v1_ufig1.gif" ALT="Figure 1"> View larger version (59K): org.highwire.dtl.DTLVardef@191e10dorg.highwire.dtl.DTLVardef@4e5093org.highwire.dtl.DTLVardef@18c0a08org.highwire.dtl.DTLVardef@e6a887_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LIIdentification of a nuclear role for the cytosolic ESCRT protein CHMP5 in transcription C_LIO_LICHMP5 mediates BRD4-dependent Pol II pause release and transcription of T-ALL genes C_LIO_LIP300-BRD4 induced enhancer and super-enhancer H3K27 acetylation requires CHMP5 C_LIO_LICHMP5 depletion mitigates chemoresistance and abrogates T-ALL initiation in vivo C_LI
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 2
- FWCI
- 1.31
- Field percentile
- top 23%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- HDAC1 regulates the chromatin landscape to establish transcriptional dependencies in chronic lymphocytic leukemia
T.-h. Lai, H. G. Ozer, … D. Sampath·bioRxiv·Aug 3, 2020
- Critical roles of Ikaros and HDAC1 in regulation of heterochromatin and tumor suppression in T-cell acute lymphoblastic leukemia
Yali Ding, Bing He, … Sinisa Dovat·LeukemiaPeer-reviewed·Jun 24, 2025
- STAT5 Gain-of-Function Variants Promote Precursor T-Cell Receptor Activation to Drive T-Cell Acute Lymphoblastic Leukemia
T. Suske, H. Sorger, … R. Moriggl·bioRxiv·Dec 21, 2022
- USP7 cooperates with NOTCH1 to drive the oncogenic transcriptionalprogram in T cell leukemia
P. Ntziachristos, K. Arcipowski, … J. D Crispino·bioRxiv·Jan 16, 2018
- Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress
A. Melnick, S. Liang, … M. Y. Chiang·bioRxiv·Jan 22, 2023
- Transgenic αβ TCR tonic signaling is leukemogenic while strong stimulation is leukemia-suppressive
Telmo A. Catarino, Ivette Pacheco-Leyva, … Nuno R. dos Santos·Journal of Leukocyte BiologyPeer-reviewed·Nov 21, 2024